These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10360831)

  • 1. bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.
    Biroccio A; Del Bufalo D; Fanciulli M; Bruno T; Zupi G; Floridi A
    Int J Cancer; 1999 Jul; 82(1):125-30. PubMed ID: 10360831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore.
    Ravagnan L; Marzo I; Costantini P; Susin SA; Zamzami N; Petit PX; Hirsch F; Goulbern M; Poupon MF; Miccoli L; Xie Z; Reed JC; Kroemer G
    Oncogene; 1999 Apr; 18(16):2537-46. PubMed ID: 10353597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
    Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O
    Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
    Del Bufalo D; Biroccio A; Soddu S; Laudonio N; D'Angelo C; Sacchi A; Zupi G
    J Clin Invest; 1996 Sep; 98(5):1165-73. PubMed ID: 8787680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R; Dong L
    Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicin-resistant HepG2 cells.
    Li YC; Fung KP; Kwok TT; Lee CY; Suen YK; Kong SK
    Life Sci; 2002 Oct; 71(23):2729-40. PubMed ID: 12383880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
    Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
    Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.
    Zupi G; Molinari A; D'Agnano I; Meschini S; Del Bufalo D; Matarrese P; Candiloro A; Calcabrini A; Citro G; Arancia G
    Anticancer Res; 1995; 15(6B):2469-77. PubMed ID: 8669810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 overexpression inhibits generation of intracellular reactive oxygen species and blocks adriamycin-induced apoptosis in bladder cancer cells.
    Kong CZ; Zhang Z
    Asian Pac J Cancer Prev; 2013; 14(2):895-901. PubMed ID: 23621258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic M‑CSF facilitates apoptosis resistance by inhibiting the HIF‑1α/BNIP3/Bax signalling pathway in MCF‑7 cells.
    Zhang M; Liu Q; Li L; Ning J; Tu J; Lei X; Mo Z; Tang S
    Oncol Rep; 2019 Mar; 41(3):1807-1816. PubMed ID: 30592292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological effector cells enhance apoptosis induced by adriamycin in a multi-drug resistant human breast cancer cell line].
    Shi YJ; Ren HY; Cen XN; Zhu Q; Yu JR
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):188-91. PubMed ID: 16875602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
    Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
    Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B; Safa AR
    Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
    Dolan ME; Frydman B; Thompson CB; Diamond AM; Garbiras BJ; Safa AR; Beck WT; Marton LJ
    Anticancer Drugs; 1998 Jun; 9(5):437-48. PubMed ID: 9660542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells.
    Osbild S; Brault L; Battaglia E; Bagrel D
    Anticancer Res; 2006; 26(5A):3595-600. PubMed ID: 17094488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
    Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
    Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
    Wu CH; Rastegar M; Gordon J; Safa AR
    Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.